Amgen (AMGN) PT Lowered to $333 at Morgan Stanley

July 8, 2026 8:07 AM

Morgan Stanley analyst Terance Flynn lowered the price target on Amgen (NASDAQ: AMGN) to $333.00 (from $340.00) while maintaining a Equalweight rating.

No results found